You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma – results of a prospective biomarker study

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma – results of a prospective biomarker study

 

Online download statistics by month:

Online download statistics by month: December 2019 to February 2026

AbstractFullPdf
Dec 2019220
Jan 202012124
Feb 202038386
Mar 202023235
Apr 2020303010
May 202031319
Jun 202040408
Jul 2020222212
Aug 2020373735
Sep 2020626223
Oct 2020696932
Nov 2020737536
Dec 2020646433
Jan 2021696932
Feb 2021606035
Mar 202112612653
Apr 2021505041
May 2021353523
Jun 2021626237
Jul 2021353514
Aug 2021454517
Sep 2021595918
Oct 2021747434
Nov 2021474736
Dec 2021444523
Jan 2022536028
Feb 2022262714
Mar 202210510628
Apr 2022414121
May 2022606123
Jun 2022434415
Jul 2022384725
Aug 2022414419
Sep 2022333520
Oct 2022313220
Nov 2022404429
Dec 2022454513
Jan 2023565716
Feb 2023474919
Mar 2023515322
Apr 2023333326
May 2023282911
Jun 2023363613
Jul 2023343417
Aug 202343439
Sep 2023404010
Oct 2023414217
Nov 2023323211
Dec 2023626323
Jan 2024696921
Feb 2024525222
Mar 2024393965
Apr 2024494934
May 202411811820
Jun 2024363613
Jul 2024424213
Aug 2024414214
Sep 2024515118
Oct 2024282812
Nov 202428296
Dec 202410710723
Jan 2025363633
Feb 202527296
Mar 2025535429
Apr 2025404018
May 2025303030
Jun 2025323319
Feb 2026110
Total314731941421